Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon‐like peptide‐1 receptor agonists

Medications for type 2 diabetes (T2DM) offer a promising path for discovery and development of effective interventions for dementia syndromes. A common feature of dementia syndromes is an energy failure due to reduced energy supply to neurons and is associated with synaptic loss and results in cogni...

Descripción completa

Detalles Bibliográficos
Autores principales: Yassine, Hussein N., Solomon, Victoria, Thakral, Angad, Sheikh‐Bahaei, Nasim, Chui, Helena C., Braskie, Meredith N., Schneider, Lon. S., Talbot, Konrad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940606/
https://www.ncbi.nlm.nih.gov/pubmed/34647685
http://dx.doi.org/10.1002/alz.12474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940606/
https://www.ncbi.nlm.nih.gov/pubmed/34647685
http://dx.doi.org/10.1002/alz.12474

Ejemplares similares